Antibody-based drugs now rival or surpass the small-molecule drugs in terms of effectivity, specificity, minimal side effects, number of ongoing […]
×
Recent Posts
- Trianni, Inc. Announces License Agreement with Zymeworks Inc. for use of the Trianni Mouse®
- Trianni, Inc. and San Diego Biomedical Research Institute Announce License Agreement for the Trianni Mouse®
- Trianni, Inc. Announces Issuance of Patent in Japan
- Trianni, Inc. and MacroGenics, Inc. Announce License Agreement
- Trianni, Inc. and Simon Fraser University Announce Licensing Agreement for The Trianni Mouse™
Archives
- September 2019
- March 2019
- February 2019
- December 2018
- September 2018
- June 2018
- March 2018
- February 2018
- December 2017
- October 2017
- June 2017
- May 2017
- March 2017
- February 2017
- October 2016
- September 2016
- August 2016
- June 2016
- May 2016
- March 2016
- February 2016
- December 2015
- November 2015
- March 2014
- September 2013
Recent Comments